BAWANG GROUP (01338) issues profit warning, expecting significant decrease in net profit for the first 10 months.
Hutchison Group (01338) issued an announcement that compared to the same period in 2023, the management expects the group's top ten in 2024 to...
The BAWANG GROUP (01338) has announced that compared to the same period in 2023, the management expects a significant decrease in the group's net profit for the first ten months of 2024.
During the first ten months of 2024, the group's revenue has slightly increased compared to the same period in 2023, and the gross profit margin has remained relatively stable. This is attributed to the group's efforts to save production costs by using renewable CECEP Solar Energy for the group's production facilities starting in 2024, as well as a reduction in depreciation. However, the group anticipates that the consolidated net profit for the first ten months of 2024 will decrease to approximately RMB 5 million (a decrease of about 64% compared to the same period last year). This is mainly due to an increase in advertising and promotional expenses for the group's products on platforms such as Douyin, JD.com, and traditional distribution channels; an increase in investment in research and development activities; and an increase in general administrative and management expenses, such as employee costs.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025